Our study elucidated that the neuroprotective effect of S100A9 disabling in ischemic stroke can be attributed to facilitating the shift of the M/M anti‐inflammatory phenotype and the efficiency of efferocytosis. Here, S100A9 is linked to ischemic stroke.